8DD6 image
Entry Detail
PDB ID:
8DD6
Title:
SARS-CoV-2 Main Protease (Mpro) H163A Mutant in Complex with GC376
Biological Source:
PDB Version:
Deposition Date:
2022-06-17
Release Date:
2023-09-27
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.25
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
I 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:ORF1a polyprotein
Mutations:H163A
Chain IDs:A
Chain Length:306
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Peptide-like Molecules
PRD_002495
Primary Citation
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease.
Nat Commun 14 5625 5625 (2023)
PMID: 37699927 DOI: 10.1038/s41467-023-40023-4

Abstact

The main protease of SARS-CoV-2 (Mpro) is an important target for developing COVID-19 therapeutics. Recent work has highlighted Mpro's susceptibility to undergo redox-associated conformational changes in response to cellular and immune-system-induced oxidation. Despite structural evidence indicating large-scale rearrangements upon oxidation, the mechanisms of conformational change and its functional consequences are poorly understood. Here, we present the crystal structure of an Mpro point mutant (H163A) that shows an oxidized conformation with the catalytic cysteine in a disulfide bond. We hypothesize that Mpro adopts this conformation under oxidative stress to protect against over-oxidation. Our metadynamics simulations illustrate a potential mechanism by which H163 modulates this transition and suggest that this equilibrium exists in the wild type enzyme. We show that other point mutations also significantly shift the equilibrium towards this state by altering conformational free energies. Unique avenues of SARS-CoV-2 research can be explored by understanding how H163 modulates this equilibrium.

Legend

Protein

Chemical

Disease

Primary Citation of related structures